Apellis adds $35M to IPO cap, sets share price target
October 31, 2017 at 12:34 PM EDT
The local biopharmaceutical company increased its IPO cap by a double-digit percentage.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.